Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells

Walkley, Carl R.; Fero, Matthew L.; Chien, Wei-Ming; Purton, Louise E.; McArthur, Grant A.
February 2005
Nature Cell Biology;Feb2005, Vol. 7 Issue 2, p172
Academic Journal
Haematopoietic stem cells (HSCs) are capable of shifting from a state of relative quiescence under homeostatic conditions to rapid proliferation under conditions of stress. The mechanisms that regulate the relative quiescence of stem cells and its association with self-renewal are unclear, as is the contribution of molecular regulators of the cell cycle to these decisions. Understanding the mechanisms that govern these transitions will provide important insights into cell-cycle regulation of HSCs and possible therapeutic approaches to expand HSCs. We have investigated the role of two negative regulators of the cell cycle, p27Kip1 and MAD1, in controlling this transition. Here we show that Mad1-/-p27Kip1-/- bone marrow has a 5.7-fold increase in the frequency of stem cells, and surprisingly, an expanded pool of quiescent HSCs. However, Mad1-/-p27Kip1-/- stem cells exhibit an enhanced proliferative response under conditions of stress, such as cytokine stimulation in vitro and regeneration of the haematopoietic system after ablation in vivo. Together these data demonstrate that the MYC-antagonist MAD1 and cyclin-dependent kinase inhibitor p27Kip1 cooperate to regulate the self-renewal and differentiation of HSCs in a context-dependent manner.


Related Articles

  • Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue. Dickhut, Andreas; Schwerdtfeger, Rainer; Kuklick, Larissa; Ritter, Markus; Thiede, Christian; Neubauer, Andreas; Brendel, Cornelia // Annals of Hematology;Nov2005, Vol. 84 Issue 11, p722 

    Mesenchymal stem cells (MSC) obtained from human bone marrow have been described as adult stem cells with the ability of extensive self-renewal and clonal expansion, as well as the capacity to differentiate into various tissue types and to modulate the immune system. Some data indicate that...

  • Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nolte, Martijn A.; Arens, Ramon; van Os, Ronald; van Oosterwijk, Michiel; Hooibrink, Berend; van Lier, René A. W.; van Oers, Marinus H. J. // Nature Immunology;Apr2005, Vol. 6 Issue 4, p412 

    The differentiation of hematopoietic stem cells into mature blood cell lineages is tightly regulated. Here we report that CD27, which is expressed on stem and early progenitor cells in bone marrow, can be important in this process. Deletion of CD27 increased the myeloid colony-forming potential...

  • Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Ott, Marion G.; Schmidt, Manfred; Schwarzwaelder, Kerstin; Stein, Stefan; Siler, Ulrich; Koehl, Ulrike; Glimm, Hanno; Kühlcke, Klaus; Schilz, Andrea; Kunkel, Hana; Naundorf, Sonja; Brinkmann, Andrea; Deichmann, Annette; Fischer, Marlene; Ball, Claudia; Pilz, Ingo; Dunbar, Cynthia; Yang Du; Jenkins, Nancy A.; Copeland, Neal G. // Nature Medicine;Apr2006, Vol. 12 Issue 4, p401 

    Gene transfer into hematopoietic stem cells has been used successfully for correcting lymphoid but not myeloid immunodeficiencies. Here we report on two adults who received gene therapy after nonmyeloablative bone marrow conditioning for the treatment of X-linked chronic granulomatous disease...

  • The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor. Karpova, D; Dauber, K; Spohn, G; Chudziak, D; Wiercinska, E; Schulz, M; Pettit, A R; Levesque, J P; Romagnoli, B; Patel, K; Chevalier, E; Dembowsky, K; Bonig, H // Leukemia (08876924);Dec2013, Vol. 27 Issue 12, p2322 

    Mobilized blood has supplanted bone marrow (BM) as the primary source of hematopoietic stem cells for autologous and allogeneic stem cell transplantation. Pharmacologically enforced egress of hematopoietic stem cells from BM, or mobilization, has been achieved by directly or indirectly targeting...

  • Enhancing bone marrow regeneration by SALL4 protein. Wenbin Liao; Aguila, Jerell R.; Yixin Yao; Jianchang Yang; Gary Zieve; Yongping Jiang; Avila, Cecilia; Lisa Senzel; Lai, Raymond; Dazhong Xu; Wei Dai; Yupo Ma // Journal of Hematology & Oncology;2013, Vol. 6 Issue 1, p1 

    Hematopoietic stem cells (HSCs) are widely used in transplantation therapy to treat a variety of blood diseases. The success of hematopoietic recovery is of high importance and closely related to the patient's morbidity and mortality after Hematopoietic stem cell transplantation (HSCT). We have...

  • Stem cells: The road not taken. Hock, Hanno; Orkin, Stuart H. // Nature;6/2/2005, Vol. 435 Issue 7042, p573 

    This article presents information related to haematopoietic stem cells (HSCs). These cells reside in bone marrow and are the source of the various blood-cell types. The classic experiments of I.L. Weissman showed that HSCs give rise to progenitor populations that can be isolated prospectively by...

  • The vascular niche: home for normal and malignant hematopoietic stem cells. Doan, P L; Chute, J P // Leukemia (08876924);Jan2012, Vol. 26 Issue 1, p54 

    Hematopoietic stem cells (HSCs) are uniquely capable of self-renewal and provision of all of the mature elements of the blood and immune system throughout the lifetime of an individual. HSC self-renewal is regulated by both intrinsic mechanisms and extrinsic signals mediated via specialized...

  • Controlling stem cell fate one substrate at a time. Garrison, Brian S.; Rossi, Derrick J. // Nature Immunology;Mar2010, Vol. 11 Issue 3, p193 

    The article focuses on the research by researcher L. Reavie and his colleagues regarding the role of the ubiquitinproteasome system in determining hematopoietic stem cell (HSC) fate. They propose a stem cell regulation in which modulation of protein stability by the ubiquitin system is used to...

  • A revised scheme for developmental pathways of hematopoietic cells: the myeloid-based model. Kawamoto, Hiroshi; Wada, Haruka; Katsura, Yoshimoto // International Immunology;Feb2010, Vol. 22 Issue 2, p65 

    Blood cells comprise very diverse cell types with a wide range of crucial functions; however, they share a common progenitor cell type—the hematopoietic stem cell (HSC). Clarifying how HSCs differentiate into these diverse cell types is important for understanding how they attain their...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics